Journal: Pharmaceuticals

Article Title: Recent Advances Regarding the Therapeutic Potential of Adapalene

doi: 10.3390/ph13090217

Figure Lengend Snippet: Classification of retinoids by generations.

Article Snippet: Adapalene (ADP) is a retinoid approved in 1996 by the U.S. Food and Drug Administration (FDA) for the treatment of acne (trade name Differin, producer Galderma) with fewer side effects than tretinoin [ , ].

Techniques:

Journal: Pharmaceuticals

Article Title: Recent Advances Regarding the Therapeutic Potential of Adapalene

doi: 10.3390/ph13090217

Figure Lengend Snippet: Physicochemical properties of adapalene (ADP).

Article Snippet: Adapalene (ADP) is a retinoid approved in 1996 by the U.S. Food and Drug Administration (FDA) for the treatment of acne (trade name Differin, producer Galderma) with fewer side effects than tretinoin [ , ].

Techniques: Molecular Weight, Solubility, Refractive Index

Journal: Pharmaceuticals

Article Title: Recent Advances Regarding the Therapeutic Potential of Adapalene

doi: 10.3390/ph13090217

Figure Lengend Snippet: Critical aspects of structure–activity relationships on adapalene (ADP).

Article Snippet: Adapalene (ADP) is a retinoid approved in 1996 by the U.S. Food and Drug Administration (FDA) for the treatment of acne (trade name Differin, producer Galderma) with fewer side effects than tretinoin [ , ].

Techniques: Activity Assay

Journal: Pharmaceuticals

Article Title: Recent Advances Regarding the Therapeutic Potential of Adapalene

doi: 10.3390/ph13090217

Figure Lengend Snippet: The off-label uses of adapalene (ADP).

Article Snippet: Adapalene (ADP) is a retinoid approved in 1996 by the U.S. Food and Drug Administration (FDA) for the treatment of acne (trade name Differin, producer Galderma) with fewer side effects than tretinoin [ , ].

Techniques:

Journal: Pharmaceuticals

Article Title: Recent Advances Regarding the Therapeutic Potential of Adapalene

doi: 10.3390/ph13090217

Figure Lengend Snippet: Adverse reactions during the treatment to topical gel with adapalene (ADP) (0.1%; 0.3%) [ 50 , 98 , 101 ].

Article Snippet: Adapalene (ADP) is a retinoid approved in 1996 by the U.S. Food and Drug Administration (FDA) for the treatment of acne (trade name Differin, producer Galderma) with fewer side effects than tretinoin [ , ].

Techniques: Introduce

Journal: Pharmaceuticals

Article Title: Recent Advances Regarding the Therapeutic Potential of Adapalene

doi: 10.3390/ph13090217

Figure Lengend Snippet: The most used active pharmaceutical ingredients (APIs) in topical combinations with adapalene (ADP).

Article Snippet: Adapalene (ADP) is a retinoid approved in 1996 by the U.S. Food and Drug Administration (FDA) for the treatment of acne (trade name Differin, producer Galderma) with fewer side effects than tretinoin [ , ].

Techniques: Cream

Journal: Pharmaceuticals

Article Title: Recent Advances Regarding the Therapeutic Potential of Adapalene

doi: 10.3390/ph13090217

Figure Lengend Snippet: Treatment regimens: oral drugs and topical pharmaceutical forms of adapalene (ADP).

Article Snippet: Adapalene (ADP) is a retinoid approved in 1996 by the U.S. Food and Drug Administration (FDA) for the treatment of acne (trade name Differin, producer Galderma) with fewer side effects than tretinoin [ , ].

Techniques: Cream

Journal: Pharmaceuticals

Article Title: Recent Advances Regarding the Therapeutic Potential of Adapalene

doi: 10.3390/ph13090217

Figure Lengend Snippet: Novel topical pharmaceutical forms with adapalene (ADP) alone or in combination with other active pharmaceutical substances (APIs)

Article Snippet: Adapalene (ADP) is a retinoid approved in 1996 by the U.S. Food and Drug Administration (FDA) for the treatment of acne (trade name Differin, producer Galderma) with fewer side effects than tretinoin [ , ].

Techniques: Formulation, Animal Model, Evaporation, Encapsulation, In Vitro, Diffusion-based Assay